- Home
- CELZ vs GTBP Comparison
CELZ vs GTBP Comparison
Compare CELZ & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELZ
- GTBP
- Stock Information
- Founded
- CELZ 1998
- GTBP 1965
- Country
- CELZ United States
- GTBP United States
- Employees
- CELZ N/A
- GTBP N/A
- Industry
- CELZ Biotechnology: Pharmaceutical Preparations
- GTBP Biotechnology: Pharmaceutical Preparations
- Sector
- CELZ Health Care
- GTBP Health Care
- Exchange
- CELZ Nasdaq
- GTBP Nasdaq
- Market Cap
- CELZ 5.5M
- GTBP 5.5M
- IPO Year
- CELZ N/A
- GTBP N/A
- Fundamental
- Price
- CELZ $2.02
- GTBP $2.23
- Analyst Decision
- CELZ
- GTBP Strong Buy
- Analyst Count
- CELZ 0
- GTBP 1
- Target Price
- CELZ N/A
- GTBP $11.00
- AVG Volume (30 Days)
- CELZ 34.9K
- GTBP 17.4K
- Earning Date
- CELZ 05-09-2025
- GTBP 05-15-2025
- Dividend Yield
- CELZ N/A
- GTBP N/A
- EPS Growth
- CELZ N/A
- GTBP N/A
- EPS
- CELZ N/A
- GTBP N/A
- Revenue
- CELZ $14,000.00
- GTBP N/A
- Revenue This Year
- CELZ N/A
- GTBP N/A
- Revenue Next Year
- CELZ N/A
- GTBP N/A
- P/E Ratio
- CELZ N/A
- GTBP N/A
- Revenue Growth
- CELZ 55.56
- GTBP N/A
- 52 Week Low
- CELZ $1.69
- GTBP $1.72
- 52 Week High
- CELZ $6.90
- GTBP $10.66
- Technical
- Relative Strength Index (RSI)
- CELZ 44.81
- GTBP 46.01
- Support Level
- CELZ $1.94
- GTBP $2.30
- Resistance Level
- CELZ $2.20
- GTBP $2.37
- Average True Range (ATR)
- CELZ 0.14
- GTBP 0.15
- MACD
- CELZ 0.04
- GTBP -0.01
- Stochastic Oscillator
- CELZ 40.00
- GTBP 14.55
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.